ALTERED DISTRIBUTION OF THE ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLE PROPIONATE RECEPTOR SUBUNIT GLUR2(4) AND THE N-METHYL-D-ASPARTATE RECEPTOR SUBUNIT NMDAR1 IN THE HIPPOCAMPUS OF PATIENTS WITH TEMPORAL-LOBE EPILEPSY
I. Blumcke et al., ALTERED DISTRIBUTION OF THE ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLE PROPIONATE RECEPTOR SUBUNIT GLUR2(4) AND THE N-METHYL-D-ASPARTATE RECEPTOR SUBUNIT NMDAR1 IN THE HIPPOCAMPUS OF PATIENTS WITH TEMPORAL-LOBE EPILEPSY, Acta Neuropathologica, 92(6), 1996, pp. 576-587
In patients with therapy-refractory temporal lobe epilepsy (TLE), alte
rations of glutamate receptors have been proposed as a mechanism for e
nhanced excitability. Using commercially available monoclonal antibodi
es specific for the N-methyl-D-aspartate (:NMDA) receptor subunit NMDA
R1 and fur the alpha-amino-3-hydroxy-5-methyl-4-isosazole propionate r
eceptor subunit GluR2(4). we have examined the distribution of these p
olypeptides in human hippocampal tissue that was surgically removed fr
om patients with intractable TLE. Surgical specimens were classified a
ccording to the presence of Ammon's horn sclerosis (AHS) or a focal le
sion in the temporal lobe. Cell counts and densitometric analysis of t
he immunoreactivity patterns were carried out for all hippocampal subf
ields. NMDAR1 and GluR2(4) levels were markedly reduced in patients wi
th AHS, primarily in those subfields with focal lesions and in control
specimens obtained at autopsy. In contrast, the molecular layer of th
e dentate gyrus (DG-ML) showed significantly higher levels of GluR2(4)
immunoreactivity in AHS compared to control tissue, while NMDAR1 show
ed no significant up-regulation in this sublayer. When the receptor st
aining intensity was normalized for alterations in neuronal density, n
o significant alterations could be detected except for an increase in
GluR2(4) in the DG-ML of patients with AHS. These changes may reflect
synaptic reorganization observed in the DG-ML of specimens from patien
ts with chronic intractable TLE.